Video: Glenn Beck’s Slick Propaganda Segment on the H1N1 Vaccination

(Fox) – On his show today, Glenn Beck covered the H1N1 virus and vaccine. He said he would not take a stand on if you should submit to the vaccination. Continue reading

Video: HHS Secretary Pushes H1N1 Vaccine, Says Americans Must Take The Shot

Sebelius cannot deflect worries over nasal flu mist containing live H1N1 virus Continue reading

Video: Doctors Concerned FluMist Vaccine Could Spread Live H1N1 Virus

Doctors and hospitals are expressing concern that the FluMist vaccine could endanger people because it contains live H1N1 virus, unlike the injectable shot that contains antibodies. With no less than 60 per cent of the U.S. population immunodeficient in one way or another, could FluMist be a pandemic waiting to happen? Continue reading

MSM: “Inhalable” H1N1 Vaccine Contains Live Virus; Available Soon

(Sep 18, 09) – If you have been paying attention than you already know that the vaccines being produced will contain a live virus. What was a surprise to me was that it will be available in a spray. Does that not seem like the worst idea ever, how will the live virus be contained when people are spraying this in the air? -ed Continue reading

FluMist: An Investigation By Dr. Sherri Tenpenny

“MedImmune, the manufacturer of FluMist, recently announced that it signed an agreement that makes FluMist, the new intranasal influenza vaccine, readily available to people as they shop at Wal-Mart, the worlds biggest retailer.” [1]As the physician in charge of a bustling Integrative medical clinic, questions about vaccines frequently arise. Continue reading

MSM: Vaccine for Swine Flu Is Ahead of Expectations

(NYTimes) – More than three million doses of swine flu vaccine will be available by the first week of October, a little earlier than had been anticipated, federal health officials announced Friday. Continue reading

MSM: AstraZeneca gets $90 million U.S. flu vaccine order

(Reuters) – AstraZeneca’s (AZN.L) MedImmune biotechnology unit has won an initial $90 million order from the U.S. government to make a live attentuated vaccine against the new H1N1 flu strain, it said on Monday. Continue reading